Dasatinib
Dasatinib | |
---|---|
Term | Dasatinib |
Short definition | Dasatinib - (pronounced) (da-SA-tih feather) medicine used alone or with other medicines to treat adults and children from 1 year of age with certain types of chronic myeloid leukemia or acute lymphoblastic leukemia that are Philadelphia chromosome positive. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Dasatinib - (pronounced) (da-SA-tih feather) medicine used alone or with other medicines to treat adults and children from 1 year of age with certain types of chronic myeloid leukemia or acute lymphoblastic leukemia that are Philadelphia chromosome positive. It is also being studied in the treatment of other types of cancer. Dasatinib blocks BCR-ABL and other proteins that can help prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called BMS-354825 and Sprycel
External links
- Medical encyclopedia article on Dasatinib
- Wikipedia's article - Dasatinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski